Publication date: December 2026 Source: Nanomedicine: Nanotechnology, Biology and Medicine, Volume 78 Author(s): Yuqing Shen, Xuan Cai, Huaijun Zheng, Zetong Zheng, Li Wu, Meng Yuan, Xi Jin, Dan Ye, Ye Feng
Hepatic delivery of FXR mRNA via lipid nanoparticles enhances the efficacy of a low-dose FXR agonist in the treatment of MASLD. // Nanomedicine: Nanotechnology, Biology and Medicine. – URL: https://www.sciencedirect.com/science/article/pii/S1549963426001371?dgcid=rss_sd_all
Hepatic delivery of FXR mRNA via lipid nanoparticles enhances the efficacy of a low-dose FXR agonist in the treatment of MASLD. Nanomedicine: Nanotechnology, Biology and Medicine. https://www.sciencedirect.com/science/article/pii/S1549963426001371?dgcid=rss_sd_all
“Hepatic delivery of FXR mRNA via lipid nanoparticles enhances the efficacy of a low-dose FXR agonist in the treatment of MASLD.” Nanomedicine: Nanotechnology, Biology and Medicine.
@article{article59614,
title = {Hepatic delivery of FXR mRNA via lipid nanoparticles enhances the efficacy of a low-dose FXR agonist in the treatment of MASLD},
journal = {Nanomedicine: Nanotechnology, Biology and Medicine},
url = {https://www.sciencedirect.com/science/article/pii/S1549963426001371?dgcid=rss_sd_all}
}
Publication date: January 2027 Source: Research in Social and Administrative Pharmacy, Volume 23, Issue 1 Author(s): Francisco Javier Ferreira-Alfaya, Pilar Bas-Sarmiento, Martina Fernández-Gutiérrez, María José Zarzuelo-Romero
Publication date: January 2027 Source: Research in Social and Administrative Pharmacy, Volume 23, Issue 1 Author(s): Iman El Sayed, Ramez Naguib Bedwany, Mai Salama, Ahmed Said Hassan Eltrass